Verseon

About:

Verseon’s breakthroughs in computational chemistry, AI, & synthesis create novel pharmaceuticals. Atom by atom, we drive innovation.

Website: http://www.verseon.com/

Twitter/X: VerseonCorp

Top Investors: John Leonard, Robert Karr

Description:

Verseon is a technology-based pharmaceutical company developing novel therapeutics for today’s challenging diseases. The company’s proprietary drug discovery platform is the first systematic, computationally-driven solution to achieve the molecular modeling accuracy necessary for rapid and cost-effective drug discovery. Verseon plans to use its platform to establish a diversified discovery pipeline across multiple disease areas. It was founded in 2002 and is headquartered in Fremont, California.

Total Funding Amount:

$125M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Fremont, California, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)verseon.com

Founders:

Adityo Prakash, David Kita, Eniko Fodor

Number of Employees:

51-100

Last Funding Date:

2019-09-16

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai